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Leading scientists in microbiome research met at Lake Titisee, Germany, in April 2014 to discuss the current
state of the field, the most urgent and unresolved questions, state-of-the-art technological advances, and
new avenues of future research. We summarize some of the concepts and themes discussed at this meeting.In the beautiful setting of Lake Titisee in the southern Black
Forest, Germany, around 50 scientists gathered on April 9–13,
2014, on the occasion of the 109th International Titisee Confer-
ence, entitled ‘‘Microbiome-Host Mutualism in the Shaping of
Host Immunity.’’ Reaching back to the early 1960s, the Titisee
Conferences organized by the Boehringer Ingelheim Fonds, a
foundation for basic research in medicine, have a longstanding
tradition in bringing together leading scientists to discuss current
progress and open questions in multiple fields of biomedical
research. The recent exciting advances made in our under-
standing of the microbiota and its tremendous effect on host
physiology and pathophysiology led the organizers Dan Littman
(Skirball Institute), Samuel Miller (University of Washington), and
Philippe Sansonetti (Institut Pasteur) to assemble a group of re-
searchers from various disciplines and methodological ap-
proaches (Figure 1). They discussed the current state of the field
and the problems that need to be overcome by the scientific
community to enable meaningful insight into the functional state
of microbial communities and their impact on host physiology
and pathophysiology, standardization and reproducibility be-
tween cohorts and laboratories, and translation of results from
basic research into therapeutic approaches.
Toward the Disease Metagenome
Adecade after the completion of theHumanGenomeProject, the
scientific community has realized that deciphering the molecular
underpinnings of common human disease requires far more than
the decoding of human genomes and polymorphisms. Instead,
many multifactorial human diseases have been associated with
a causative ‘‘environmental’’ component. In addition to their
own cells, comprising around 20,000 genes, human beings har-
bor trillions of microorganisms whose collective metagenome is
estimated to be around 100- to 1,000-fold larger. As such, a
considerable part of the variability in humanphysiology and path-
ophysiology that has so far been ascribed to ‘‘environmental’’
influences is potentially due to interindividual variability in their
microbial metagenome. Recently, two large-scale consortia, the
Human Microbiome Project (HMP) and the Metagenomics of
the Human Intestinal Tract (MetaHIT) project, have attempted to
captureandclassify this variability. Analogous to thepost-Human
Genome Project years dominated by genome-wide association
studies, the challenge ahead now is to functionally link this vari-
ability to disease outcome using metagenome-wide association
studies. This concept is currently applied to amultitude of patho-
logic conditions, including inflammatory bowel disease (IBD),
metabolic diseases, stem cell transplantation, and skin disease.662 Cell Host & Microbe 15, June 11, 2014 ª2014 Elsevier Inc.Peer Bork (EuropeanMolecular Biology Laboratory) presented
recent data from the MetaHIT project. Network analysis of
species abundance in various cohorts further supports the
concept that intestinal community structures can be classified
into recurrent clusters, designated ‘‘enterotypes.’’ On a deeper
level, each individual might have a unique metagenome, due to
polymorphisms in bacterial genomes and individual-specific
strains (Schloissnig et al., 2013). Curtis Huttenhower (Harvard
School of Public Health) presented follow-up studies to the
HMP that focus on characterizing the microbiome involved in
IBD and its various clinical manifestations and complications.
The main effort in these studies is to determine characteristic
compositional and functional microbiota profiles associated
with disease states and to develop predictive measures for
microbiome-based diagnosis. Recently, a large pediatric cohort
of Crohn’s disease patients revealed a signature of microbial
communities associated with this disease (Gevers et al., 2014).
Richard Blumberg (Harvard University) focused on the host
side of the complex etiology of IBD. Genome-wide association
studies of IBD patients have highlighted three recurrent path-
ways to be involved in the genetic susceptibility to IBD: innate
immune pathways of the NOD-like family of receptors, genes
involved in autophagy, and the ER stress and unfolded protein
response. A unifying concept is emerging by which these
pathways do not act in isolation, but rather integrate into a
network of cooperation and compensation (Adolph et al.,
2013). Bringing together the microbial profiles associated with
disease and the genetic susceptibility loci of the host will remain
a central challenge of the next decade in IBD research.
Eric Pamer (Memorial Sloan-Kettering Cancer Center)
described human fecal microbiota analyses in patients following
allogeneic hematopoietic stem cell transplantation that corre-
lated a marked survival benefit with increased commensal flora
diversity. Marcel Van den Brink (Memorial Sloan-Kettering
Cancer Center) presented work establishing a connection
between the gut microbiota dysbiosis and intestinal inflamma-
tion secondary to graft-versus-host disease (GVHD) (Jenq
et al., 2012). Certain members of the microbiota can function
as biomarkers for GVHD severity, and modulation of the micro-
biota composition prior to transplantation affects the outcome
of GVHD. Pamer and Van den Brink also discussed the
challenges facing the field in translating laboratory-derived
findings into therapeutic, microbiota-altering modalities. At the
clinical level, ongoing efforts must integrate data from multiple
study centers and establish common readouts and clinical
endpoints. In the laboratory, the mechanisms involved in
Figure 1. Participants of the 109th
International Titisee Conference Organized
by the Charitable Boehringer Ingelheim
Fonds on ‘‘Microbiome-Host Mutualism in
the Shaping of Host Immunity’’ at Lake
Titisee, Germany
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Somemicrobiota-generated metabolites are providing glimmers
of hope that they may function as therapeutic agents or clinical
targets.
Eugene B. Chang (University of Chicago) demonstrated an
example of how Western diets can trigger experimental colitis
in genetically susceptible IL-10-deficient mice. A diet high in
saturated fats promoted taurine conjugation of hepatic bile
acids, and in turn, taurine, which is a rich source of organic
sulfate, caused a bloom of sulphite-reducing bacteria, resulting
in a proinflammatory immune response and exacerbation of
colitis in the IL-10-deficient host (Devkota et al., 2012). These
data suggest that environmental factors (e.g., diet), together
with host factors that affect gut microbial assemblage, can
determine immune response, risk of disease, and clinical pheno-
type. Since metabolite abundances in the intestinal lumen and
lamina propria are reflective of the functional state of the micro-
biota, sensing of metabolites, rather than mere bacterial pres-
ence, may be the most informative variable according to which
the host adapts homeostatic set points in pathways communi-
cating with the microbiota.
In addition to intestinal inflammation, the microbiota also
strongly influences metabolic diseases. Jayne Danska (Hospital
for Sick Children, University of Toronto) provided an interesting
perspective on the role of early-life microbial exposure in type
1 diabetes. After puberty, male and female nonobese diabetic
mice feature distinct microbial configurations, which modulate
sex hormone levels and control susceptibility to autoimmunity
(Markle et al., 2013). Similar recent findings by the group of Alex-
ander Chervonsky (University of Chicago) (Yurkovetskiy et al.,
2013) fuelled new efforts to determine interventions against
type 1 diabetes that are independent of the microbiota. Such
interventions should feature higher robustness across age and
gender. Based on recent findings, Chervonsky discussed
various novel dietary approaches with microbiota-independentCell Host & Microbeeffects as a new avenue for clinically
related microbiome research.
Samuel Miller (University of Washing-
ton) applied the concept of disease-asso-
ciated dysbiosis to cystic fibrosis, which
includes gastrointestinal inflammation
and malabsorption of nutrients. Children
with cystic fibrosis feature significantly
higher levels of fecal Escherichia coli, a
signature that is commonly observed in
inflammatory settings (Hoffman et al.,
2014; Stecher et al., 2013). This bloom
of Enterobacteriaceae during intestinal
inflammation was elaborated on by
Andreas Ba¨umler (University of California
at Davis). The inflammatory responseinduces alterations in gene expression in intestinal tissue. One
prominent change involves the production of reactive nitrogen
species that are converted to nitrate in the inflamed intestine.
The majority of commensal Enterobacteriaceae are equipped
with nitrate-reducing enzymes that confer competitive advan-
tage under such situations of nitrate enrichment (Winter et al.,
2013). This new knowledge is now exploited to assess selective
interventions targeting anaerobic respiration of Enterobacteria-
ceae. This example shows how mechanistic knowledge about
host-microbiota crosstalk in the disease setting can lead to
powerful interventional strategies.
Julie Segre (National Institutes of Health) is characterizing the
disease-associated microbiota at a different site, the skin. The
fungal microbiome of the skin is dominated by the genus
Malassezia at most body sites; only foot colonization features
higher diversity (Findley et al., 2013). Analogous to the intestinal
microbiome, current efforts are focusing on characterizing
dysbiosis involved in skin disease. First insights into the micro-
biota associated with atopic dermatitis suggest that dysbiosis
of the skinmay be useful as a diagnostic indicator and potentially
as therapeutic target.
Toward a Systematic Understanding of Colonization
Principles
In addition to profiling of microbiota configurations associated
with specific diseases, the convergence of bioinformatics, data
processing, genomic sequencing, and high-throughput technol-
ogies now enables systematic approaches to understanding
host-microbiota interactions. Andrew Goodman (Yale School
of Medicine) has developed a transposon-based approach that
enables screening for genomic components in members of the
commensal microbiota that facilitate membership and interac-
tion within the bacterial community. This approach is able to
uncover components of themetagenome that promotemicrobial
fitness within the intestinal ecosystem. For instance, the15, June 11, 2014 ª2014 Elsevier Inc. 663
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encodes for three vitamin B12 transporters that appear to be
nonredundant, but rather confer competitive advantage during
intestinal colonization (Degnan et al., 2014). Systematic explora-
tion of themetagenome for factors involved in colonization of the
gut ecosystem will be instrumental for generating a more
comprehensivemap of genetic factors involved in host-microbial
and intermicrobial crosstalk. Another promising approach is the
generation of metagenomic libraries that can be screened for
their effect on the host. Joe¨l Dore´ (French National Institute for
Agricultural Research) presented a strategy employing func-
tional metagenomics that complement proteomics screening
efforts to generate metabolite profiles characteristic of distinct
bacterial compositions. Such a bacterial protein profile was
recently generated for Crohn’s disease patients (Juste et al.,
2014).
Nassos Typas (European Molecular Biology Laboratory)
further emphasized the high dimensionality of microbe-microbe
interactions, within and across animal kingdoms, which take
place in the human intestine. Screening of bacterial mutants in
the presence or absence of other members of the commensal
microbiota, an approach complementary to the abovementioned
transposon-based approach in vivo, yields interesting insight
into interdependencies of microbial species and the network
architectures of intestinal colonization. Julie Pfeiffer (University
of Texas Southwestern Medical Center) characterized the inter-
play between intestinal bacteria and enteric viruses. Following
the initial observation that the microbiota promotes virus replica-
tion and pathogenesis, her group has recently uncovered direct
binding of viruses to bacterial LPS, thus increasing virion stability
and transmission (Robinson et al., 2014). Functional conse-
quences of bacterial-viral interactions and parasite-viral interac-
tions on the immune system were discussed by David Artis. His
laboratory is using coinfection models to decipher the modula-
tory capacity of distinct classes of microbes on the host immune
system and the consequences for subsequent exposure to
different microorganisms.
Another instance of interbacterial crosstalk was discussed by
Jon Clardy (Harvard Medical School) in the context of his talk on
the use of host-microbe systems to trace evolution. Using two
bacterial strains isolated from the red seaweed as a model, the
siderophore avaroferrin was discovered as an inhibitor of bacte-
rial swarming, the rapid movement over a surface (Bo¨ttcher and
Clardy, 2014). Nicole King (University of California, Berkeley)
employs the choanoflagellate Salpingoeca rosetta to study
host-bacterial interactions in a simple model organism. Her
work revealed that molecules generated by prey bacteria modu-
late colony formation of the host. This model system is well
suited to discover fundamental principles of interkingdom
coevolution that can be applied to mammalian colonization by
bacteria.
Complementary to the systematic exploration of the metage-
nome by genetic means and bacterial interactions by using
microbial ecology, the application of mathematical modeling to
symbiotic communities has recently yielded new ideas about
the concepts underlying microbial colonization of the intestine.
One of these concepts is the idea that the host can influence
microbial colonization to yield a precise biogeography of the
intestine. Kevin Foster (University of Oxford) reported on inter-664 Cell Host & Microbe 15, June 11, 2014 ª2014 Elsevier Inc.esting computer simulations that suggest that nutrients (Schluter
and Foster, 2012) and antibodies secreted from the epithelium
can strongly affect the positioning of commensals in the intestine.
Ultimately, a mechanistic understanding of host-microbiota
interaction might require architectural understanding of mole-
cules involved in this crosstalk. The central challenge is to
capture and visualize protein transport across membranes,
which is pivotal for intercellular communication and information
flow. Thomas Marlovits (Institute for Molecular Biotechnology,
Vienna) demonstrated examples for the successful structural
characterization of such information flow. His group has recently
characterized protein transport across bacterial type III secretion
systems, a major mechanism involved in host-microbial and
intermicrobial communication (Radics et al., 2014).
Taken together, understanding host-microbiota interactions
requires the application of principles derived from ecology and
genomics to a new context: a high-dimensional multikingdom
ecosystem of prokaryotic-eukaryotic interplay. This challenge
can be met from various perspectives, and a combination
of mathematical modeling, genomic screening, and classical
microbiology will prove fruitful in future research.
Toward Mechanisms of Host Immune Shaping
One of the most striking effects of intestinal microbial coloniza-
tion on the host is the modulation of the immune system. First
studies of germ-free mice had noted altered architecture of
intestinal lymphoid structures and distorted compartments of
lymphoid cells. This was followed by seminal studies identifying
direct induction of immune cell populations by distinct microbes.
Dan Littman (Skirball Institute) and Kenya Honda (RIKEN Yoko-
hama) presented exciting new findings following the initial dis-
covery of segmented filamentous bacteria (SFB) as inducers of
T helper 17 (TH17) cells and Clostridia as inducers of regulatory
T (Treg) cells. Littman demonstrated that TH17 cells induced by
SFB recognize SFB-specific antigen, even in the presence of
additional, TH1-inducing microbes in the intestine (Yang et al.,
2014). These findings suggest an interesting concept, namely a
direct match between antigen specificity of a T cell and the
type of bacteria that influence the T cell’s effector function.
Honda elaborated on the specific properties of SFB as inducers
of TH17 cells and presented interesting insights into differential
induction of RORgt-expressing TH17 cells and RORgt-express-
ing innate lymphoid cells (ILCs). He also focused on recent
work identifying a cocktail of Clostridia spp. as inducers of
another subset of Treg cells, a finding with great potential for
the therapeutic modulation of intestinal inflammation (Atarashi
et al., 2013). The fact that interactions between the host immune
system and the microbiota are not a one-way communication of
bacterial induction of T cells was discussed by Sidonia
Fagarasan (RIKEN Yokohama). She took the example of Treg
cells to describe the importance of immune homeostasis for a
stable microbial community. Interestingly, aberrations in Treg
function and germinal center reactions lead to alterations in
microbial diversity in the intestine.
The challenge ahead in deciphering microbiome-host mutu-
alism in the shaping of host immunity is to integrate the many
variables and pathways that are involved in this crosstalk.
Such a regulatory network has emerged from the work of Fiona
Powrie (University of Oxford) over the last decade. Her group has
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kines for the interplay between T cell subsets in the intestine
and the intestinal microbiota. Intestinal Treg cells play a critical
role in maintaining tolerance against commensal antigens. New
data now suggest a role for the alarmin IL-33 in this complex
network.
Another layer of signal integration happens at the epigenetic
level. Koji Hase (University of Tokyo) presented a new mecha-
nism for the control of intestinal Treg homeostasis. Gut microbial
colonization induces the DNA-methylation adaptor Uhrf1 in Treg
cells. This leads to methylation and silencing of the gene encod-
ing for cyclin-dependent kinase inhibitor p21, thereby driving the
proliferation and functional maturation of colonic Treg cells
(Obata et al., 2014). The importance of epigenetic regulation in
intestinal epithelial cells was emphasized by David Artis
(University of Pennsylvania). Deletion of histone deacetylase 3
(HDAC3) in epithelial cells results in a loss of Paneth cells, devel-
opment of dysbiosis, and enhanced susceptibility to intestinal
inflammation. Interestingly, these phenotypes are dependent
on the presence of the microbiota, suggesting that epigenetic
remodeling is necessary for appropriate integration of microbial
signals to the host (Alenghat et al., 2013). John Rawls (Duke
University Medical Center) reported on a genome-wide
approach to decipher the impact of microbial colonization on
chromatin accessibility and transcript levels in the intestinal
epithelium. Comparison of both small and large intestine
between germ-free and colonized mice indicated that transcrip-
tional responses to microbiota are not accompanied by changes
in chromatin accessibility, but are instead linked to altered
expression of specific transcriptional regulatory factors.
A further aspect of transcriptional control of intestinal lympho-
cyte function was discussed by Lora Hooper (University of Texas
Southwestern Medical Center). Her group recently found that
TH17 cells in the gut are controlled by elements of the circadian
clock. The transcription factor Rev-Erba, a component of the
molecular clock, is negatively regulating another transcription
factor, Nfil3, which in turn negatively controls RORgt, the line-
age-defining transcription factor of TH17 cells (Yu et al., 2013).
This finding suggests that intestinal immunity may be controlled
by regulatory principles of whole-organism physiology that have
so far been overlooked. It will be interesting to determine in the
future whether more such regulatory systems are involved in
the shaping of intestinal immunity.
Yasmine Belkaid (National Institutes of Health) focused on the
interaction between the microbiota and the immune system at
the skin. Studies from her laboratory have defined a role for the
skin microbiota in controlling the local T cell response to com-
mensals and pathogens (Naik et al., 2012). The concept that
emerged from these studies suggests that each mucosal site
is defined by autonomous mutual feedback loops of host-
microbiota mutualism.
These recent findings about antigen specificity of microbiota-
induced T cells and the strict compartmentalization of
tissue-specific antibacterial immunity suggest the existence a
regulatory relay that links microbial recognition to T cell activa-
tion. Such a relay is likely provided by antigen-presenting cells.
Belkaid elaborated on distinct functional assignments to subsets
of mononuclear phagocytes (MNPs) in the skin. Maria Rescigno
(European Institute of Oncology) studies such MNP populationsin the intestine and recently discovered antigen transfer between
the two major classes of lamina propria MNPs: CX3CR1
+ and
CD103+ cells. This antigen transfer was essential for the induc-
tion of oral tolerance and might be an example of howMNP sub-
sets with distinct functions can cooperate to maintain tolerance
at mucosal surfaces, while at the same time retaining the ability
to rapidly react against pathogenic insults (Mazzini et al., 2014).
Antigen-presenting cells link microbial signals to lymphocyte
activation. However, the direct recognition of microbial products
happens further upstream and is performed by receptors of the
innate immune system. Dana Philpott (University of Toronto)
focused on a family of innate immune receptors called
Nod-like receptors (NLRs). NLRs have recently emerged as cen-
tral regulators of the intestinal immune response to bacteria
(Philpott et al., 2014), andmutations in NLRs are frequently found
in IBD patients. Philpott provided insight into the role of a yet
poorly understood member of the large NLR family, NLRC3.
Her work pointed to a role of this protein in T cell regulation.
Innate immune receptors are a highly conserved class of pro-
teins, and many homologs are found in nonvertebrates. Bruno
Lemaitre (Ecole Polytechnique Fe´de´rale de Lausanne) has
made pivotal contributions to understanding the innate immune
system of Drosophila melanogaster and its interactions with the
microbiota. He highlighted the key role of intestinal stem cells
and epithelial repair in the defense against oral bacterial infec-
tion. He also showed how the Drosophila immune response is
compartmentalized along the digestive tract (Buchon et al.,
2013) and presented interesting new results on the impact of
the Drosophila microbiota on gut compartmentalization and tis-
sue renewal (Broderick et al., 2014). Filipe Cabreiro (University
College London) studies the impact of microbial drug meta-
bolism on longevity in Caenorhabditis elegans. He recently
discovered that the biguanide drug metformin alters microbial
metabolism (Cabreiro et al., 2013). In addition to Drosophila
andCaenorhabditis, the zebrafishDanio rerio is a versatile model
to study host-microbiota interactions. Karen Guillemin (Univer-
sity of Oregon) has set up a germ-free zebrafish system, which
allows for systematic assessment of immune cell responses to
microbial colonization in this transparent model organism.
In addition to lymphocytes, nonhematopoietic cells have
recently been recognized as important immune cells in the
orchestration of host-microbiota interactions. Mucus-secreting
goblet cells promote the spatial segregation between the epithe-
lial layer and the majority of microbes in the intestinal lumen.
Over the last decades, the work of Gunnar Hansson (University
of Gothenburg) has revealed the composition and function of
the mucus layer secreted by goblet cells. In the colon, the inner
mucus layer is normally devoid of bacteria. Interestingly, recent
findings indicate that this spatial separation is lost in IBD patients
(Johansson et al., 2014). Thaddeus Stappenbeck (Washington
University) has recently defined epithelial autophagy as a control
mechanism regulating paneth cell and goblet cell function (Patel
et al., 2013). He presented interesting new findings on the func-
tion of mucus-associated commensal B. thetaiotaomicron and a
new means of communication between the bacteria and the
intestinal mucosa. Andrew Macpherson (University of Bern)
elaborated on the role of mucus in the stratification of bacterial
colonization in the intestine. His laboratory has developed
a tool to reversibly colonize germ-free mice (HapfelmeierCell Host & Microbe 15, June 11, 2014 ª2014 Elsevier Inc. 665
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persistence. In addition, reversible colonization can be used to
determine the impact of distinct phases of microbial exposure
during life. The arguably most critical phase of microbial coloni-
zation is the neonatal period. Early colonization profoundly
affects immune system maturation, with lifelong consequences.
Matthias Hornef (Hannover Medical School) characterized the
interdependency of immune system development and gut
microbial ecology after birth (Renz et al., 2012) and presented
interesting new findings on the consequences of this process
for disease susceptibility.
Together, the next decade in research on shaping of immunity
by the microbiota will aim at deepening our mechanistic under-
standing of bacterial functions necessary to induce appropriate
host responses, myeloid cells as communicators between
immune compartments, and the role of epithelial cells as media-
tors of host immune responses.
Toward New Perspectives
Ruslan Medzhitov (Yale School of Medicine) presented, in an
inspiring keynote lecture, an evolutionary perspective on host-
microbiome interactions and a conceptual overview of the chal-
lenges that the field is facing in the years to come. While many
examples have been found for functional complementation
leading to functional dependency between host and microbiota
(such as the one found in vitamin biosynthesis pathways), a
similarly important, albeit much less studied, aspect of host-
microbiota interactions is the niche construction ability of
microorganisms, i.e., their ability to alter the capacity of an
ecological niche in favor of the microorganism. He hypothe-
sized that the types of interactions between the host and mem-
bers of the microbiota might be classifiable into a limited
number of categories based on commonalities in the functional
consequences for both sides. This means that coevolution of
host and members of the microbiota might have followed com-
mon repetitive patterns with respect to hallmark variables of
microbial colonization (including microbial density, attachment
to host cells, and metabolite production) and the host appro-
priate host response (including development of a specific
immune response and metabolic adaptation). Understanding
these features will be a challenging yet promising avenue of
future research.
Furthermore, the evolution of host genes may appear in a new
perspective when considered under the circumstance of host-
microbiota coevolution. For instance, the adaptation of a host
organism to a new environment during evolution might have
occurred not only by direct adaptation but rather by facilitating
adaptation through the microbiome. In other words, the function
of some host genes might be to modulate the adaptation of the
microbiome to selective pressure. Eran Elinav (Weizmann
Institute of Science) presented evidence that immune genes
involved in host-microbiota interactions may serve as ‘‘buffers’’
that enable the response of themicrobiota to changes in environ-
mental conditions. He presented his work on the role of the
inflammasomes, host sensors of the innate immune system, in
intestinal epithelial cells, where they are involved in shaping of
microbial composition and in creating a physical barrier between
host and microbial cells by promoting mucus secretion
(Wlodarska et al., 2014). Importantly, the functional conse-666 Cell Host & Microbe 15, June 11, 2014 ª2014 Elsevier Inc.quence of dysbiosis for host fitness in the absence of inflamma-
somes is context dependent, and thus inflammasomes might
provide a bone fide example for host pathways facilitating
the adaptive capability of the microbiota to environmental
conditions.
The resilience of the microbiota to a change in external condi-
tions was also discussed by Eric Alm (Massachusetts Institute of
Technology), who followed changes in the human microbiome
over the course of a year. He elaborated on factors controlling
the stability of the microbiota and presented interesting insight
into the differential roles of a and b diversity in this regard.
The meeting also aimed at formulating the conceptual diffi-
culties that this young field is facing and at discussing conditions
that need to be met for a productive future. Samuel Miller raised
the question of whether the current taxonomical species
concept still captures the relevant variables when analyzing a
large microbial community like the intestinal microbiota, as func-
tions could be contained across species, and thus functional
classifications might be far superior to the species concept.
Furthermore, he noted that standardized model systems will
be of great benefit for the field moving ahead. Tools envisioned
include well-defined microbial communities for mouse models,
animal models of microbiota-mediated disease and their human
correlates, human epithelial model systems, and standards for
the implementation and evaluation of fecal transplantation.
Taken together, this meeting reflected on the tremendous
progress made over the recent years in our understanding of
host-microbiota interactions and the multiperspective approach
that needs to be taken when studying this fascinating part of
human physiology and pathophysiology. It also sought to define
new standards that must be applied when analyzing the many
variables characterizing this community, as the importance of
the majority of these variables remains unknown. A systematic
understanding of the microbiome has the potential to transform
modern medicine, and this is an important time for establishing
the right conditions for a productive decade ahead in micro-
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